Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents - comment

Michael Tsatsos^{1

2

3

4}, Cheryl MacGregor², Ioannis Athanasiadis³, Marilita M Moschos⁴, Sazan Jameel⁵, Parwez Hossain², David Anderson²

Affiliations

¹ Royal Eye Infirmary, Dorset County Hospital NHS Foundation Trust, Dorchester, UK.
² Southampton University Hospitals NHS Foundation Trust, Southampton, UK.
³ Moorfields Eye Hospital NHS Foundation Trust, London, UK.
⁴ University of Athens, Athens, Greece.
⁵ Hawler Medical University, Erbil, Iraq.

Comment

Michael Tsatsos et al. Clin Exp Ophthalmol. 2017 Dec.

. 2017 Dec;45(9):932.

doi: 10.1111/ceo.12991. Epub 2017 Jun 21.

Michael Tsatsos^{1

2

3

4}, Cheryl MacGregor², Ioannis Athanasiadis³, Marilita M Moschos⁴, Sazan Jameel⁵, Parwez Hossain², David Anderson²

¹ Royal Eye Infirmary, Dorset County Hospital NHS Foundation Trust, Dorchester, UK.
² Southampton University Hospitals NHS Foundation Trust, Southampton, UK.
³ Moorfields Eye Hospital NHS Foundation Trust, London, UK.
⁴ University of Athens, Athens, Greece.
⁵ Hawler Medical University, Erbil, Iraq.

No abstract available

Comment on

Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.
Tsatsos M, MacGregor C, Athanasiadis I, Moschos MM, Hossain P, Anderson D. Tsatsos M, et al. Clin Exp Ophthalmol. 2016 Dec;44(9):824-837. doi: 10.1111/ceo.12785. Epub 2016 Jul 26. Clin Exp Ophthalmol. 2016. PMID: 27273328 Review.